Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
RESEARCH TOOLSreports
Arcutis Biotherapeutics (ARQT) Ownership - Who Owns Arcutis Biotherapeutics?
670 Followers
Arcutis Biotherapeutics (ARQT) Ownership Overview
15.42% Insiders
26.24% Mutual Funds
14.75% Other Institutional Investors
43.60% Public Companies and Individual Investors
The ownership structure of Arcutis Biotherapeutics (ARQT) stock is a mix of institutional, retail and individual investors. Approximately 40.98% of the company’s stock is owned by Institutional Investors, 15.42% is owned by Insiders and 43.60% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jul 02, 2024 | Howard G. Welgus Director | xxxxxxxxxxxxx | $93100 |
| Jun 06, 2024 | Howard G. Welgus Director | xxxxxxxxxxxxx | $80065 |
| May 31, 2024 | Patrick Burnett Reporting Person's Title: Svp Chief Medical Officer | xxxxxxxxxxxxx | $636332 |
| May 29, 2024 | Masaru Matsuda Reporting Person's Title: Svp Gc And Corporate Secretary | xxxxxxxxxxxxx | $15975 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $133448 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $198200 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $334105 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $7432500 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,361,563 | Institution | 4.63% | 52,275,239 | |
| 4,902,800 | Institution | 4.24% | 47,802,300 | |
| 4,508,866 | Institution | 3.89% | 43,961,444 | |
| 4,234,951 | Institution | 3.66% | 41,290,772 | |
| 3,725,459 | Institution | 3.22% | 36,323,225 | |
| 3,389,514 | Institution | 2.93% | 33,047,762 | |
| 2,846,856 | Institution | 2.46% | 27,756,846 | |
| 2,807,130 | Institution | 2.42% | 27,369,518 | |
| 2,764,502 | Institution | 2.39% | 26,953,895 | |
| 1,883,945 | Institution | 1.63% | 18,368,464 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,508,866 | Institution | 3.89% | 43,961,444 | |
| 3,725,459 | Institution | 3.22% | 36,323,225 | |
| 3,389,514 | Institution | 2.93% | 33,047,762 | |
| 2,846,856 | Institution | 2.46% | 27,756,846 | |
| 1,883,945 | Institution | 1.63% | 18,368,464 | |
| 1,766,984 | Institution | 1.53% | 17,228,094 | |
| 1,439,616 | Institution | 1.24% | 14,036,256 | |
| 1,113,210 | Institution | 0.96% | 10,853,798 | |
| 947,381 | Institution | 0.82% | 9,236,965 | |
| 835,108 | Institution | 0.72% | 8,142,303 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,955,871 | Institution | 2.55% | 27,489,600 | |
| 2,806,557 | Institution | 2.42% | 27,363,931 | |
| 2,666,635 | Institution | 2.30% | 26,053,024 | |
| 1,556,015 | Institution | 1.34% | 14,470,940 | |
| 1,385,268 | Institution | 1.20% | 12,399,507 | |
| 948,803 | Institution | 0.82% | 9,250,829 | |
| 667,104 | Institution | 0.58% | 6,504,264 | |
| 498,471 | Institution | 0.43% | 4,870,062 | |
| 443,042 | Institution | 0.38% | 4,328,520 | |
| 443,042 | Institution | 0.38% | 4,328,520 |
FAQ
Who Owns Arcutis Biotherapeutics (ARQT)?
According to the latest TipRanks data, approximately 14.75% of the company's stock is held by institutional investors, 15.42% is held by insiders, and 43.60% is held by retail investors.
What percentage of Arcutis Biotherapeutics (ARQT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 14.75% of Arcutis Biotherapeutics (ARQT) stock is held by institutional investors.
What percentage of Arcutis Biotherapeutics (ARQT) stock is held by retail investors?
According to the latest TipRanks data, approximately 43.60% of Arcutis Biotherapeutics (ARQT) stock is held by retail investors.
Who owns the most shares of Arcutis Biotherapeutics (ARQT)?
Vanguard owns the most shares of Arcutis Biotherapeutics (ARQT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.